Robert Gottliebsen in Bus Spec gives a good summary on CSL
http://www.businessspectator.com.au/article/2013/3/21/health-and-pharmaceutical/healthy-pressure-csl-successor
I think he is saying. CSL is not overpriced if the expected earnings come through as projected and that CSLs black swan is any new technology that severely negatively impacts its business.
peaked?, page-38
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$301.12 |
Change
0.350(0.12%) |
Mkt cap ! $145.5B | |||
| Open | High | Low | Value | Volume |
| $301.69 | $304.00 | $298.71 | $230.4M | 764.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 32 | $301.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $301.13 | 937 | 1 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |